Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).

Saved in:
Bibliographic Details
Title: Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).
Authors: Chauhan A; University of California, San Francisco, California., Weiss HL; University of Kentucky , Markey Cancer Center, Lexington, Kentucky., Kunos C; University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida., Jayswal R; University of Kentucky , Markey Cancer Center, Lexington, Kentucky., Konda B; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Soares HP; University of Utah , Salt lake City, Utah., Li D; City Of Hope National Medical Center , Medical Oncology & Therapeutics Research, Duarte, California., Halfdanarson TR; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Mulcahy MF; Department of Medicine, Northwestern University, Chicago, Illinois., Jacene HA; Department of Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Khurana A; University of Kentucky , Markey Cancer Center, Lexington, Kentucky., Modak R; University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida., Yan D; University of Kentucky , Markey Cancer Center, Lexington, Kentucky., Beumer JH; Sidney Kimmel Comprehensive Cancer Center , Baltimore, Maryland., Christner SM; UPMC Hillman Cancer Center , University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania., Wu PI; Frederick National Laboratory for Cancer Research , Molecular Characterization Laboratory, Frederick, Maryland., Das B; Frederick National Laboratory for Cancer Research , Molecular Characterization Laboratory, Frederick, Maryland., Rubinstein LV; National Cancer Institute , Cancer Therapy Evaluation Program, Rockville, Maryland., Gore SD; National Cancer Institute , Cancer Therapy Evaluation Program, Rockville, Maryland., Ivy SP; National Cancer Institute , Investigational Drug Branch, Bethesda, Maryland., Kohn EC; National Cancer Institute , Cancer Therapy Evaluation Program, Rockville, Maryland., Carson WE; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio., Anthony LB; University of Kentucky , Markey Cancer Center, Lexington, Kentucky., Arnold SM; University of Kentucky , Markey Cancer Center, Lexington, Kentucky.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Oct 15; Vol. 32 (20), pp. 4612-4621.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-26-0686